Back to results
RecruitingPhase 4

A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland

NCT07502560

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Espoo, Finland

+7 additional locations

Contact

US GSK Clinical Trials Call Center

877-379-3718GSKClinicalSupportHD@gsk.com
View on ClinicalTrials.gov
A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland — TrialFind